Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 1;879(23):2274-80. doi: 10.1016/j.jchromb.2011.06.012. Epub 2011 Jun 15.
We report on the quantitative determination of acetaminophen (paracetamol; NAPAP-d(0)) in human plasma and urine by GC-MS and GC-MS/MS in the electron-capture negative-ion chemical ionization (ECNICI) mode after derivatization with pentafluorobenzyl (PFB) bromide (PFB-Br). Commercially available tetradeuterated acetaminophen (NAPAP-d(4)) was used as the internal standard. NAPAP-d(0) and NAPAP-d(4) were extracted from 100-μL aliquots of plasma and urine with 300 μL ethyl acetate (EA) by vortexing (60s). After centrifugation the EA phase was collected, the solvent was removed under a stream of nitrogen gas, and the residue was reconstituted in acetonitrile (MeCN, 100 μL). PFB-Br (10 μL, 30 vol% in MeCN) and N,N-diisopropylethylamine (10 μL) were added and the mixture was incubated for 60 min at 30 °C. Then, solvents and reagents were removed under nitrogen and the residue was taken up with 1000 μL of toluene, from which 1-μL aliquots were injected in the splitless mode. GC-MS quantification was performed by selected-ion monitoring ions due to M-PFB and M-PFB-H, m/z 150 and m/z 149 for NAPAP-d(0) and m/z 154 and m/z 153 for NAPAP-d(4), respectively. GC-MS/MS quantification was performed by selected-reaction monitoring the transition m/z 150 → m/z 107 and m/z 149 → m/z 134 for NAPAP-d(0) and m/z 154 → m/z 111 and m/z 153 → m/z 138 for NAPAP-d(4). The method was validated for human plasma (range, 0-130 μM NAPAP-d(0)) and urine (range, 0-1300 μM NAPAP-d(0)). Accuracy (recovery, %) ranged between 89 and 119%, and imprecision (RSD, %) was below 19% in these matrices and ranges. A close correlation (r>0.999) was found between the concentrations measured by GC-MS and GC-MS/MS. By this method, acetaminophen can be reliably quantified in small plasma and urine sample volumes (e.g., 10 μL). The analytical performance of the method makes it especially useful in pediatrics.
我们报告了一种通过 GC-MS 和 GC-MS/MS 在电子捕获负离子化学电离(ECNICI)模式下,用五氟苄基(PFB)溴化物(PFB-Br)衍生后,定量测定人血浆和尿液中对乙酰氨基酚(扑热息痛;NAPAP-d(0))的方法。商用的全氘代对乙酰氨基酚(NAPAP-d(4))被用作内标。NAPAP-d(0)和 NAPAP-d(4)通过涡旋(60 秒)从 100μL 等分血浆和尿液中用 300μL 乙酸乙酯(EA)提取。离心后收集 EA 相,用氮气流除去溶剂,残留物用乙腈(MeCN,100μL)重新溶解。加入 10μL PFB-Br(30vol%在 MeCN 中)和 N,N-二异丙基乙胺(10μL),混合物在 30°C 下孵育 60 分钟。然后,氮气下除去溶剂和试剂,用 1000μL 甲苯提取残留物,从中取 1μL 等分试样在不分流模式下进样。GC-MS 通过选择离子监测离子进行定量,分别针对 NAPAP-d(0)的M-PFB和M-PFB-H,m/z 150 和 m/z 149,以及 NAPAP-d(4)的 m/z 154 和 m/z 153。GC-MS/MS 通过选择反应监测过渡 m/z 150→m/z 107 和 m/z 149→m/z 134 对 NAPAP-d(0)进行定量,对 NAPAP-d(4)进行 m/z 154→m/z 111 和 m/z 153→m/z 138 进行定量。该方法在人血浆(NAPAP-d(0)浓度范围 0-130μM)和尿液(NAPAP-d(0)浓度范围 0-1300μM)中进行了验证。准确度(回收率,%)在这些基质和范围内介于 89%至 119%之间,精密度(RSD,%)低于 19%。在 GC-MS 和 GC-MS/MS 测量的浓度之间发现了密切的相关性(r>0.999)。通过该方法,可以在小体积的血浆和尿液样本(例如 10μL)中可靠地定量对乙酰氨基酚。该方法的分析性能使其在儿科中特别有用。